AbbVie (ABBV)

$152.25 0.88 (0.57%)

19:00 EDT ABBV Stock Quote Delayed 30 Minutes

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor Sep 26, 2023

With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.

7 Safe and Steady Dividend Stocks to Buy for Volatile Time

The Top 7 Underrated Dividend Stocks Yielding 3% or More

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 3.70M

Day's Range $151.37 - $153.83

52-Week Range $130.96 - $168.11

Dividend & Yield $5.20 (3.42%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

The 3 Most Promising Biotech Stocks to Own Now

By Michael Que, InvestorPlace Contributor Aug 31, 2023

These top biotech stock picks with high and leading growth potential are must-owns for investors looking for high upside potential.

Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity

By Yiannis Zourmpanos, InvestorPlace Contributor Aug 29, 2023

Seizing a selected group of blue-chip stocks may lead to unparalleled growth for investors.

7 Stocks to Buy for the Rest of 2023

By Muslim Farooque, InvestorPlace Contributor Aug 29, 2023

With the stock market off to a bombastic start, these top stocks for 2023 are worth betting on for the remainder of the year

Late-Summer Steals: 7 Stocks to Buy Before Fall

By Josh Enomoto, InvestorPlace Contributor Aug 28, 2023

With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.

7 Very Oversold High-Yield Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor Aug 23, 2023

For speculators wanting to gamble the conservative way, these oversold high-yield stocks to buy may be what you’re looking for.

7 Top Dividend Stocks for Income and Stability

By Thomas Niel, InvestorPlace Contributor Aug 21, 2023

Strong fundamentals and long dividend growth track records make these the top seven dividend stocks to buy.

Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035

By Rich Duprey, InvestorPlace Contributor Aug 17, 2023

As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence.

7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now

By Alex Sirois, InvestorPlace Contributor Aug 14, 2023

These shares of blue-chip stocks to buy continue to be attractive for smart investors who value strong firms and steady performance.

7 Dividend Stocks to Buy as Investor Sentiment Falters

By Josh Enomoto, InvestorPlace Contributor Aug 14, 2023

With economic uncertainty rising, investors can ride out the potential storm with these dividend stocks to buy.

3 Pharma Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 11, 2023

Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.

Sell Alert: 3 Healthcare Stocks to Dump ASAP

By Larry Ramer, InvestorPlace Contributor Aug 3, 2023

These healthcare stocks to dump now will continue to be weighed down by legal issues and/or slumping sales.

The 7 Best Dividend Stocks to Protect Your Portfolio From Global Chaos

By Josh Enomoto, InvestorPlace Contributor Jul 24, 2023

With global events only rising in entropy, investors ought to consider these best dividend stocks for portfolio protection.

3 of the Best Dividend Stocks to Buy for Passive Income Growth

By Chris MacDonald, InvestorPlace Contributor Jul 20, 2023

For investors looking to create a meaningful stream of passive income in retirement, these dividends stocks are great options.

7 Fantastic Forever Stocks for Long-Term Lucrative Gains

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2023

These forever stocks to buy offer compelling bull cases for the long-haul, alongside spectacular upside potential.

3 Biotech Stocks to Sell Before They Damage Your Portfolio

By Larry Ramer, InvestorPlace Contributor Jul 12, 2023

With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point.

The 3 Best Dividend Stocks to Buy in July

By Joel Baglole, InvestorPlace Contributor Jul 7, 2023

Not all stocks pay dividends, and not all dividend payments are equal. Some dividends are more generous than others, and investors seeking to maximize their income need to pay attention to the yield offered on dividend stocks.

The 7 Best Long-Term Stocks to Buy in July

By Josh Enomoto, InvestorPlace Contributor Jul 6, 2023

Although it might not be the most exciting approach, the best long-term stocks in July offer a greater chance of upside success.

The 7 Best Forever Stocks to Buy for July 2023

By Josh Enomoto, InvestorPlace Contributor Jul 5, 2023

With the market throwing some curveballs, investors may find more confidence engaging the best forever stocks to buy.

The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023

By Joel Baglole, InvestorPlace Contributor Jun 30, 2023

Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks.

7 Stocks That Every 40-Year-Old Should Buy Today

By Josh Enomoto, InvestorPlace Contributor Jun 27, 2023

Having reached the halfway point in life, make your market moves count with the best investments for 40-year-olds.

AbbVie (ABBV)

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

7 Safe and Steady Dividend Stocks to Buy for Volatile Time

The Top 7 Underrated Dividend Stocks Yielding 3% or More

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AbbVie (ABBV)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABBV Stock Predictions, Articles, and AbbVie News

Subscriber Sign in